Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minoxidil + spironolactone vs minoxidil + finasteride for androgenic alopecia
IRCT20211210053343N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of minoxidil, spironolactone and finasteride in androgenetic alopecia (AGA) (2 arms), sponsored by Iran University of Medical Sciences. Started Jan 2022; status: completed.
02
Drugs
minoxidilspironolactonefinasteride
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on IRCT20211210053343N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211210053343N1.